Research progress on macrophage regulation of atherosclerosis

Jiahui Song1,2, Rui Yan1, Ping Li1

  • 1Department of Cardiology, Beijing Luhe Hospital, Capital Medical University, Beijing, China.

PubMed

Insights

Macrophages play a key role in atherosclerosis, a major cause of cardiovascular diseases (CVDs). This review explores how these immune cells drive plaque development and discusses new therapeutic strategies for atherosclerosis.

Area of Science:

  • Cardiovascular Biology
  • Immunology
  • Pathology

Background:

  • Cardiovascular diseases (CVDs) are a leading cause of global mortality and disability.
  • Atherosclerosis is a primary pathological process underlying CVDs.
  • Macrophages are critical cellular players in atherosclerosis initiation, plaque progression, and rupture.

Purpose of the Study:

  • To review the mechanisms of macrophage involvement in atherosclerosis.
  • To summarize recent therapeutic advances targeting macrophage functions in atherosclerosis treatment and prevention.

Main Methods:

  • Literature review of current evidence on macrophage roles in atherosclerosis.
  • Synthesis of research on therapeutic strategies targeting macrophages.

Main Results:

  • Macrophages contribute significantly to plaque development and instability.
  • Understanding macrophage mechanisms offers potential therapeutic targets.

Conclusions:

  • Macrophages are central to atherosclerosis pathogenesis.
  • Targeting macrophages presents promising avenues for novel atherosclerosis therapies.

Related Concept Videos

Inflammation01:38

Inflammation

Overview
62.6K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.5K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
465
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
670